Innoviva Stock Price (NASDAQ:INVA)

Add to My Stocks
$12.09 $0.14 (1.14%) INVA stock closing price May 25, 2017 (Closing)
26 MAY 2017
amigobulls logo
INVA hand_up
INVA vs S&P 500
Closing Price: May 25, 2017
$12.09 ( -1.14%)
S&P 500
2415.1 ( 0.44%)
52 Week Price Range
1 Year Return: 6.52%
Q4 Growth*
Profitable ?
net image
2016 Q4 Net Profit
PE Valuation
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

Innoviva Snapshot Video

13 5 2

INVA Stock Details

Prev Close* : $12.23
Market Cap:
Day Low: $12
52 Week Low: $8.67
Open: $12.25
Volume: 664632
Day High: $12.36
52 Week High: $14.55

Latest Stock Market News

Latest Articles

Innoviva News - From Partners

INVA Stockcharts

View INVA PE ratio, PS ratio stocks charts and compare with peers.
INVA Chart
Note: Compare Innoviva stock price history with the index and industry peers.

Innoviva Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio

Innoviva Financial Ratios

Asset Turnover
Receivables Turnover

INVA Industry Peers

Company Price Change (%)
Repligen (RGEN)38.860.04 (0.1%)
Emergent Biosolutions (EBS)30.20.07 (0.23%)
Glaxosmithkline (GSK)42.570.38 (0.88%)
Aradigm (ARDM)1.290.03 (2.27%)
Skyepharma (SKYEY)6.280.02 (0.32%)
Merck (MRK)65.040.11 (0.17%)
Vertex Pharma (VRTX)118.60.8 (0.68%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MannKind (MNKD)1.420.14 (10.94%)
Revance (RVNC)21.250.85 (4.17%)
Puma Biotech (PBYI)78.053.1 (4.14%)
NeoGenomics (NEO)7.550.28 (3.85%)
Sinovac Biotech (SVA)5.050.17 (3.48%)
Chromadex (CDXC)3.230.08 (2.54%)
Intra-Cellular Therapies (ITCI)10.490.23 (2.24%)
Top gainers from Medical-Biomed-Genetics industry
* As of May 26, 2017
CompanyPriceChange (%)
Vital Therapies (VTL)2.8250.38 (11.88%)
Inovio Pharma (INO)7.990.69 (7.95%)
ALBIREO PHARMA (ALBO)19.141.63 (7.85%)
AMAG Pharma (AMAG)18.21.05 (5.45%)
Lion Biotech (LBIO)6.150.35 (5.38%)
ZIOPHARM Oncology (ZIOP)6.570.35 (5.06%)
Sarepta Therapeutics (SRPT)30.851.64 (5.05%)
Top losers from Medical-Biomed-Genetics industry
* As of May 26, 2017

Innoviva Inc Stock News - Partner Headlines

Innoviva Financial Statements

income statement20162015201420132012
Net Sales Or Revenues133.56M53.94M8.43M4.75M135.75M
Net Income59.53M-18.76M-168.46M-170.7M-18.54M
Total Operating Expense24.57M22.36M42.35M173.62M148.74M
view Innoviva Inc income statement
balance sheet20162015201420132012
Total Assets378.99M424.07M521.65M681.25M368.58M
Total Liabilities731.98M766.71M745M382.13M213.55M
Shareholders Equity-352.99M-342.64M-223.34M299.12M155.02M
view Innoviva Inc balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-21.96M-16.85M-30.25M5.77M-140.7M
Net Cash From (Used By) Operating Activities60.98M10.13M-130.72M-129.6M-127.95M
Increase (Decrease) In Prop Plant And Equipment-0.27M-0.01M-135.68M-2.73M-2.59M
view Innoviva Inc cashflow statement

Innoviva Stock Message Board

Innoviva stock lost -1.14 %, and the last close price as of 25 May, 2017 is 12.09 for INVA stock. The total market value as denoted by 1.34B for Innoviva, is the market value of the company's outstanding shares. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Innoviva stock analysis.

Demand for a stock decides its stock market price. For example, if more investors want to buy INVA stock than sell it, then Innoviva stock price goes up. Conversely, if more investors wanted to sell INVA stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume number in Innoviva stock quote data shows the number of shares traded. For Ex: 664632 Innoviva shares were traded as of last trading day, as seen from Innoviva stock chart. To check the historical stock price movement, all time high, and all time low of INVA, view Innoviva stock price history.